Proteasome inhibitor carfilzomib complements ibrutinib’s action in chronic lymphocytic leukemia

समान संसाधन

• Pharmacological and protein profiling suggest venetoclax (ABT-199) as optimal partner with ibrutinib in chronic lymphocytic leukemia
  द्वारा: Cervantes-Gomez, Fabiola, और अन्य
  प्रकाशित: (2015)
• Carfilzomib triggers cell death in chronic lymphocytic leukemia by inducing proapoptotic and endoplasmic reticulum stress responses
  द्वारा: Lamothe, Betty, और अन्य
  प्रकाशित: (2016)
• Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cells
  द्वारा: Cervantes-Gomez, Fabiola, और अन्य
  प्रकाशित: (2015)
• Preclinical combination of TP-0903, an AXL inhibitor and B-PAC-1, a procaspase-activating compound with ibrutinib in chronic lymphocytic leukemia
  द्वारा: Patel, Viralkumar, और अन्य
  प्रकाशित: (2015)
• Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib
  द्वारा: Vitale, Candida, और अन्य
  प्रकाशित: (2016)